United States · 
Who invested in Callio Therapeutics?
Callio Therapeutics's investors include Norwest Venture Partners, Novo Holdings, EDBI and Omega Funds.
United States · Series A startup
Who invested in Callio Therapeutics
Funding summaryUpdated 26 Oct 2026
$187Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $187MMar 2025
- Investors
- 4
The rounds
- Mar 2025
Founders and team
From Callio Therapeutics's own website: 4 on the team.
- Zachary HornbyChief Executive Officer
- Kevin HamblyChief Business Officer
- Kiran AsarpotaChief Operating Officer
- Meredith WesleyChief Human Resources Officer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Callio Therapeutics
How much has Callio Therapeutics raised?
Callio Therapeutics has raised $187M across 1 round since 2025.
When did Callio Therapeutics last raise?
Callio Therapeutics's most recent round was a Series A of $187M in Mar 2025.
What was Callio Therapeutics's biggest round?
Its most recent round, $187M in Mar 2025, is also its largest on record.
Who backed Callio Therapeutics first?
Callio Therapeutics's first round on record, in Mar 2025, was backed by Norwest Venture Partners, Novo Holdings and EDBI and 1 others.
What stage is Callio Therapeutics at?
Callio Therapeutics's latest named round is a Series A, in Mar 2025.
Where is Callio Therapeutics based?
Callio Therapeutics is based in the United States.
Companies like Callio Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.